A revolutionary drug , retatrutide, is sparking considerable excitement within the Oz weight management community. Created by the company, this twin GIP and GLP-1 receptor appears to provide more significant results than existing therapies. Preliminary medical trials have shown exceptional reductions in physical weight , raising a for a new strateg